Search results
Results from the WOW.Com Content Network
The use of technology has begun to be implemented in ABA therapy for the treatment of autism. [49] Robots, gamification, image processing, story boards, augmented reality, and web systems have been shown to be useful in the treatment of autism. [49] These technologies are used to teach children with autism skill acquisition. [49]
Founded in 1971 by Eric Schopler, TEACCH provides training and services geared to helping autistic children and their families cope with the condition. [2] [17] Gary B. Mesibov, a professor and researcher on UNC's TEACCH program since about 1979, was director of the program from 1992 to 2010. [18] [19]
The relationship between autism and memory, specifically memory functions in relation to autism spectrum disorder (ASD), is an ongoing topic of research. ASD is a neurodevelopmental disorder characterised by social communication and interaction impairments, along with restricted and repetitive patterns of behavior.
CDD is a rare condition, with only 1.7 cases per 100,000. [13] [14] [15]A child affected with childhood disintegrative disorder shows normal development. Up until this point, the child has developed normally in the areas of language skills, social skills, comprehension skills, and has maintained those skills for about two years.
Treatment of childhood dementia focuses on managing symptoms and improving quality of life. This can include: Medications: Anti-seizure medications, behaviour-modifying drugs, and muscle relaxants. [1] Therapies: Physiotherapy, occupational therapy, and speech therapy are used to maintain physical function for as long as possible. [1]
A dementia charity has hailed a “historic moment” in Alzheimer’s research as a new drug has been found to reduce memory decline among patients with early-stage disease.
Some drugs used to treat type 2 diabetes could also help lower a person’s risk of neurodegenerative diseases, such as Alzheimer’s. Image credit: martin-dm/Getty Images.
A recent study found that a class of medications called SGLT-2 inhibitors—which does not include Ozempic or similar drugs like Zepbound—significantly lowered the risk of dementia in people ...